Massimo Bogliolo - Concepedia

Author

Massimo Bogliolo

Universitat Autònoma de Barcelona ORCID

Also Known As

Bogliolo, Massimo, M Bogliolo, M. Bogliolo, Massimo Bogliolo

Publications

Citations

H-Index

Concepts

All Affiliations

Universitat Autònoma de Barcelona Centre for Biomedical Network Research on Rare Diseases Hospital de Sant Pau Instituto de Salud Carlos III Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas

About

Massimo Bogliolo is an author at Universitat Autònoma de Barcelona specializing in medicine, genetics, and molecular genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1.1K
2	Health Sciences	3	3	215
3	Natural Sciences	1	1	16
4	Public Health	1	1	25
5	Biochemistry	1	1	23

Massimo Bogliolo

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi Anemia Massimo Bogliolo, Beatrice Schuster, Chantal Stoepker, The American Journal of Human Genetics Genome InstabilityGenetic DisorderGeneticsMolecular BiologyDna-repair Endonuclease Xpf	2013	303
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia Susana Navarro, Wei Wang, Rebeca Sánchez‐Domínguez, Nature Medicine Fanconi AnemiaCell TherapyNon-conditioned PatientsDevelopmental BiologyBone Marrow Failure	2019	170
Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability Massimo Bogliolo, Alex Lyakhovich, Elsa Callén, The EMBO Journal ChromatinChromosome StabilityChromatin RemodelingEpigenetic ChangeGenetics	2007	131
Mutations in TOP3A Cause a Bloom Syndrome-like Disorder Carol-Anne Martin, Kata Sarlós, Clare V. Logan, The American Journal of Human Genetics Mendelian DisorderGenetic DisorderGeneticsTop3a CauseMolecular Genetics	2018	94
<i>FANCM</i>c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor Paolo Peterlongo, Irene Catucci, Mara Colombo, Human Molecular Genetics	2015	93
Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility Irene Catucci, Ana Osório, Brita Arver, Genetics in Medicine	2017	91
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia Francisco J Roman‐Rodriguez, Laura Ugalde, Lara Álvarez, Cell stem cell Fanconi AnemiaGenome InstabilityGeneticsMolecular BiologyGenetic Engineering	2019	85
Biallelic truncating FANCM mutations cause early-onset cancer but not Fanconi anemia Massimo Bogliolo, Dominique Bluteau, James Lespinasse, Genetics in Medicine Fanconi AnemiaFancm MutationsGenetic DisorderGeneticsHematology	2017	78
From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia Csilla Krausz, Antoni Riera‐Escamilla, Chiara Chianese, Genetics in Medicine HematologyPathologyMedicineIdiopathic AzoospermiaEpidemiology	2018	55
Detection of the `4977 bp' mitochondrial DNA deletion in human atherosclerotic lesions Massimo Bogliolo Mutagenesis	1999	47

Page 1